Tranexamic acid versus placebo to reduce perioperative blood transfusion in patients undergoing liver resection: protocol for the haemorrhage during liver resection tranexamic acid (HeLiX) randomised controlled trial

INTRODUCTION: Despite use of operative and non-operative interventions to reduce blood loss during liver resection, 20%–40% of patients receive a perioperative blood transfusion. Extensive intraoperative blood loss is a major risk factor for postoperative morbidity and mortality and receipt of blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Karanicolas, Paul Jack, Lin, Yulia, McCluskey, Stuart, Roke, Rachel, Tarshis, Jordan, Thorpe, Kevin E, Ball, Chad G, Chaudhury, Prosanto, Cleary, Sean P, Dixon, Elijah, Eeson, Gareth, Moulton, Carol-Anne, Nanji, Sulaiman, Porter, Geoff, Ruo, Leyo, Skaro, Anton I, Tsang, Melanie, Wei, Alice C, Guyatt, Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883280/
https://www.ncbi.nlm.nih.gov/pubmed/35210348
http://dx.doi.org/10.1136/bmjopen-2021-058850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883280/
https://www.ncbi.nlm.nih.gov/pubmed/35210348
http://dx.doi.org/10.1136/bmjopen-2021-058850

Ejemplares similares